David A. Siegel Twist Bioscience Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 280,500 shares of TWST stock, worth $11.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
280,500
Previous 340,000
17.5%
Holding current value
$11.8 Million
Previous $16.8 Million
24.37%
% of portfolio
0.03%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding TWST
# of Institutions
256Shares Held
66.8MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$254 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$237 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$229 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$226 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$154 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.38B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...